Back to discover
Disease
Spasm
Late-stage therapeutic developmentEmerging research
1
Publications
19
Clinical trials
2020
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Research2020-07-24Journal of clinical oncology : official journal of the American Society of Clinical Oncology
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Moderate
Key developments
- 3 clinical trials expected to report results, the earliest in Q4 2026.
Upcoming Milestones
- Q4 2026A Phase II Study of Fenfluramine for Treatment of Refractory Infantile Spasms
- Q1 2027The Safety and Efficacy of DaxibotulinumtoxinA-Lanm for Benign Essential Blepharospasm and Hemifacial Spasm
- Q4 2027A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Examine The Efficacy And Safety Of ZX008 In Subjects With CDKL5 Deficiency Disorder Followed By An Open-Label Extension
Major developments
Upcoming trial readoutHigh impact
Results expected Q4 20272026-04-29
Upcoming trial readoutHigh impact
Results expected Q1 20272026-04-23
Clinical MilestonesViewHide
Results posted
- 2025-10-10The Role of Oral Verapamil in Preventing Radial Spasm During Transradial AngiographyResults posted
Results expected
- 2026-04-29A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Examine The Efficacy And Safety Of ZX008 In Subjects With CDKL5 Deficiency Disorder Followed By An Open-Label ExtensionResults expected Q4 2027
- 2026-04-23The Safety and Efficacy of DaxibotulinumtoxinA-Lanm for Benign Essential Blepharospasm and Hemifacial SpasmResults expected Q1 2027
- 2026-04-15A Phase II Study of Fenfluramine for Treatment of Refractory Infantile SpasmsResults expected Q4 2026
Recently completed
- 2026-06-01Efficacy of Vigabatrin With High Dose Prednisolone Combination Therapy Versus Vigabatrin Alone for Infantile Spasm: a Randomized TrialPrimary completion
- 2026-03-15Effect of Intravenous Lidocaine Infusion on Duodenal Peristalsis, Sedation Quality and Rescue Spasmolytic Requirement in ERCP Procedures: A Randomized, Double-Blind, Placebo-Controlled StudyCompleted
- 2025-12-01Efficacy and Safety of the Fixed-Dose Combination of Etoricoxib / Tizanidine Versus Etoricoxib in the Treatment of Patients With Acute Low Back Pain Associated to Muscle SpasmCompleted
Other updates
- 2025-12-30A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic PainTerminated
Activity timeline8
- 2026-06-01ClinicalEfficacy of Vigabatrin With High Dose Prednisolone Combination Therapy Versus Vigabatrin Alone for Infantile Spasm: a Randomized TrialPrimary completion
- 2026-04-29ClinicalA Phase 3, Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Multicenter Study To Examine The Efficacy And Safety Of ZX008 In Subjects With CDKL5 Deficiency Disorder Followed By An Open-Label ExtensionResults expected Q4 2027
- 2026-04-23ClinicalThe Safety and Efficacy of DaxibotulinumtoxinA-Lanm for Benign Essential Blepharospasm and Hemifacial SpasmResults expected Q1 2027
- 2026-04-15ClinicalA Phase II Study of Fenfluramine for Treatment of Refractory Infantile SpasmsResults expected Q4 2026
- 2026-03-15ClinicalEffect of Intravenous Lidocaine Infusion on Duodenal Peristalsis, Sedation Quality and Rescue Spasmolytic Requirement in ERCP Procedures: A Randomized, Double-Blind, Placebo-Controlled StudyCompleted
- 2025-12-30ClinicalA Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic PainTerminated
- 2025-12-01ClinicalEfficacy and Safety of the Fixed-Dose Combination of Etoricoxib / Tizanidine Versus Etoricoxib in the Treatment of Patients With Acute Low Back Pain Associated to Muscle SpasmCompleted
- 2025-10-10ClinicalThe Role of Oral Verapamil in Preventing Radial Spasm During Transradial AngiographyResults posted
Clinical trials
The current development programme across all trial phases.
Clinical programme
19
6
13
6
Late-stage studies
Recruiting
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Leading journals1
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology1
Leading researchers8
- Bahary N1
- Bates SE1
- Bullock AJ1
- Chondros D1
- de la Fouchardiere C1
- Fazio N1
- Hammel P1
- Heinemann V1
Affiliations (unnormalised)6
- and Université de Paris1
- Beth Israel Deaconess Medical Center1
- Catalan Institute of Oncology (ICO)1
- Centre Léon Bérard1
- Columbia University Irving Medical Center1
- Department of Internal Medicine III and Comprehensive Cancer Center1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
An involuntary contraction of a muscle or group of muscles. Spasms may involve SKELETAL MUSCLE or SMOOTH MUSCLE.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.